RxDoctor Payments Data

Christopher Coulson, DO

Family Medicine · Dover, OHNPI 1932124229

Payments from drug & device makers

$382in general payments, 2019–2025

Across 24 payments — averaging $15.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$80
  • Corcept Therapeutics$69
  • Boehringer Ingelheim$30
  • AstraZeneca$30
  • AbbVie$26
  • Abbott$26
  • plus $121 from 7 others

What the payments were for

  • Food & beverage$382100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$382 in reported general payments places this provider in the 45th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$34,075
Medicare patients
142
Services billed
811

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide110$125,282
EliquisApixaban42$44,283
MounjaroTirzepatide26$37,892
JardianceEmpagliflozin22$27,741
FarxigaDapagliflozin Propanediol26$24,306
TrulicityDulaglutide11$12,086
Spiriva RespimatTiotropium Bromide12$5,953
Lantus SolostarInsulin Glargine,hum.Rec.Anlog36$5,319
ShingrixVaricella-Zoster Ge/As01b/Pf22$4,735
Atorvastatin Calcium344$2,771
Lansoprazole25$2,203
Metoprolol Succinate172$2,109
Losartan Potassium238$2,012
BreynaBudesonide/Formoterol Fumarate13$1,776
Albuterol Sulfate HfaAlbuterol Sulfate87$1,507

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$80$125,282110 claims
Lilly USA, LLCMounjaro, Trulicity$12$49,97837 claims
PfizerEliquis$15$44,28342 claims
Boehringer IngelheimJardiance, Spiriva Respimat$30$33,69434 claims
AstraZenecaFarxiga$30$24,30626 claims
GSKShingrix$23$4,73522 claims
AbbVieSynthroid$26$76839 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Dover

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →